AAAAAA

   
Results: 1-9 |
Results: 9
Progression from superficial to invasive carcinoma of the bladder: Geneticevidence of either clonal or heterogeneous events
Authors: Volante, M Tizzani, A Casetta, G Zitella, A Pacchioni, D Bussolati, G
Citation: M. Volante et al., Progression from superficial to invasive carcinoma of the bladder: Geneticevidence of either clonal or heterogeneous events, HUMAN PATH, 32(5), 2001, pp. 468-474
Bladder tumor antigen assay as compared to voided urine cytology in the diagnosis of bladder cancer
Authors: Priolo, G Gontero, P Martinasso, G Mengozzi, G Formiconi, A Pelucelli, G Zitella, A Casetta, G Viberti, L Aimo, G Tizzani, A
Citation: G. Priolo et al., Bladder tumor antigen assay as compared to voided urine cytology in the diagnosis of bladder cancer, CLIN CHIM A, 305(1-2), 2001, pp. 47-53
Enhanced urinary gelatinase activities (matrix metalloproteinases 2 and 9)are associated with early-stage bladder carcinoma: A comparison with clinically used tumor markers
Authors: Sier, CFM Casetta, G Verheijen, JH Tizzani, A Agape, V Kos, J Blasi, F Hanemaaijer, R
Citation: Cfm. Sier et al., Enhanced urinary gelatinase activities (matrix metalloproteinases 2 and 9)are associated with early-stage bladder carcinoma: A comparison with clinically used tumor markers, CLIN CANC R, 6(6), 2000, pp. 2333-2340
Evaluation of p53 protein overexpression, ki67 proliferative activity and mitotic index as markers of tumour recurrence in superficial transitional cell carcinoma of the bladder
Authors: Gontero, P Casetta, G Zitella, A Ballario, R Pacchioni, D Magnani, C Muir, GH Tizzani, A
Citation: P. Gontero et al., Evaluation of p53 protein overexpression, ki67 proliferative activity and mitotic index as markers of tumour recurrence in superficial transitional cell carcinoma of the bladder, EUR UROL, 38(3), 2000, pp. 287-296
Bladder pheochromocytoma: A 3-year follow-up after transurethral resection(TURB)
Authors: Baima, C Casetta, G Vella, R Tizzani, A
Citation: C. Baima et al., Bladder pheochromocytoma: A 3-year follow-up after transurethral resection(TURB), UROL INTERN, 65(3), 2000, pp. 176-178
BTA quantitative assay and NMP22 testing compared with urine cytology in the detection of transitional cell carcinoma of the bladder
Authors: Casetta, G Gontero, P Zitella, A Pelucelli, G Formiconi, A Priolo, G Martinasso, G Mengozzi, G Aimo, G Viberti, L Tizzani, A
Citation: G. Casetta et al., BTA quantitative assay and NMP22 testing compared with urine cytology in the detection of transitional cell carcinoma of the bladder, UROL INTERN, 65(2), 2000, pp. 100-105
Immunohistochemical evaluation of the safety of transurethral electrovaporization of the prostate and its clinical results
Authors: Tizzani, A Gontero, P Casetta, G Piana, P Baima, C de Zan, A Bodo, G Pacchioni, D
Citation: A. Tizzani et al., Immunohistochemical evaluation of the safety of transurethral electrovaporization of the prostate and its clinical results, PROSTATE C, 2(1), 1999, pp. 16-20
Presence of urokinase-type plasminogen activator receptor in urine of cancer patients and its possible clinical relevance
Authors: Sier, CFM Sidenius, N Mariani, A Aletti, G Agape, V Ferrari, A Casetta, G Stephens, RW Brunner, N Blasi, F
Citation: Cfm. Sier et al., Presence of urokinase-type plasminogen activator receptor in urine of cancer patients and its possible clinical relevance, LAB INV, 79(6), 1999, pp. 717-722
Recurrent calcium oxalate urolithiasis in a man with familial periodic paralysis and hypokalemia
Authors: Zitella, A Moiso, A De Zan, A Casetta, G Piana, P Tizzani, A
Citation: A. Zitella et al., Recurrent calcium oxalate urolithiasis in a man with familial periodic paralysis and hypokalemia, J UROL, 161(6), 1999, pp. 1899-1899
Risultati: 1-9 |